Clinical Trial

Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-13; most recent amendment 2025-02-25.
Trial Details
NCT Number NCT06040476
Lead Sponsor StemCyte, Inc.
Collaborators: StemCyte Taiwan Co., Ltd.
Conditions Acute Ischemic Stroke
Enrollment 39 participants
Start Date 2025-09
Primary Completion 2027-12 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2025-02-27